Alpha-lipoic acid and quercetin protect against methotrexate induced-hepatotoxicity in rats

HealthMED

Volumn 3, Issue 1, 2009, Pages 80-89

  Darwish, Hebatallah A ^a   Mahdy, Amina ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

lipoic acid; Methotrexate; Nitric oxide; Oxidative stress; Quercetin; TNF

Indexed keywords

EID: 77949453134     PISSN: 18402291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Abdel-Zaher, A.O., Abdel-Hady, R.H., Mahmoud, M.M., & Farrag, M.M. (2008). The potential protective role of alpha-lipoic acid against acetaminophen-induced hepatic and renal damage. Toxicology, 243 (3), 261-270.
2. nd ed.), Vol. 2, Verlag Chemic, Weinheim, pp. 673.
3. Babiak, R.M., Campello, A.P., Carnieri, E.G., & Oliveira, M.B. (1998). Methotrexate: pentose cycle and oxidative stress. Cell Biochem. Funct., 16, 283-93.
4. Beutler, E., Duron, O. & Kelly, B.M. (1963). Improved method for the determination of blood glutathione. J. Lab. Clin. Med., 61, 882-888.
5. Bilska, A., & Wlodek, L. (2005). Lipoic acid - the drug of the future? Pharmacological reports, 57,570-577.
6. Bowie, A.G., Moynagh, P.N., & O'Neill, L.A. (1997). Lipid peroxidation is involved in the activation of NF-kB by tumor necrosis factor but not interleukin-1 in the human endothelial cell line ECV304. Lack of involvement of H2O2 in NF-kB activation by either cytokine in both primary and transformed endothelial cells. J. Biol. Chem., 272, 25941-25950.
7. Busse, E., Zimmer, G., Schopohl, B., & Kornhuber, B. (1992). Influence of alpha-lipoic acid on intracellular glutathione in-vitro and in-vivo. Arzneimittelforschung, 42, 829-831.
8. Caetano, N.N., Campello, A.P., Carnieri, E.G., Kluppel, M.L., & Oliveira, M.B. (1997). Effects of methotrexate (MTX) on NAD(P)+ dehydrogenases of HeLa cells: malic enzymes, 2-oxogluterate and isocitrate dehydrogenases. Cell Biochem. Funct., 15, 259-264.
9. Cetinkaya, A., Bulbuloglu, E., Kurutas, E.B., & Kantarceken, B. (2006). N-acetylcysteine ameliorates methotrexate-induced oxidative liver damage in rats. Med. Sci. Monit., 12(8), 274-278.
10. Chladek, J., Martinkova, J., & Sispera, L. (1997). An in-vitro study on methotraxate hydroxylation in rat and human liver. Physiol. Res., 46, 371-379.
11. Coldiron, A.D., Sanders, R.A., & Watkins, J.B. (2002). Effects of combined quercetin and coenzyme Q(10) treatment on oxidative stress in normal and diabetic rats. J. Biochem. Mol. Toxicol., 16, 197-202.
12. Deneke, S.M. & Fanburg, B.L. (1989). Regulation of cellular glutathione. Am. J. Physiol., 257, L163-L173.
13. Dias, A.S., Porawski, M., Alonso, M., Marroni, N., Collado, P.S. & Gonzalez-Gallego, J. (2005). Quercetin decreases oxidative stress, NF-kB activation, and iNOS over expression in liver of streptozotocin-induced diabetic rats. J. Nutr., 135, 2299-2304.
14. Duarte, J., Galisteo, M., Ocete, M.A., Pérez-Vizcaino, F., Zarzuelo, A., & Tamargo, J. (2001). Effect of chronic quercetin treatment on hepatic oxidative status in spontaneously hypertensive rats. Mol. Cell Biochem., 221, 155-160.
15. Erden Inal, M., & Kahraman, A. (2000). The protective effect of flavonol quercetin against ultraviolet A-induced oxidative stress in rats. Toxicology, 154, 21-9.
16. Galivan, J., Nimec, Z., & Balinska, M. (1983). Regulation of methotrexate polyglutamate accumulation in vitro: effects of cellular folate content. Biochem. Pharmacol., 32, 3344-3347.
17. Gordon, M.H., & Roedig-Penman, A. (1998). Antioxidant activity of quercetin and myricetin in liposomes. Chem. Phys. Lipids, 97, 79-85.
18. Grisham, M.B., Jourd'Heuil, D., & Wink, D.A. (1999). Nitric oxide. I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am. J. Physiol., 276, G315-G321.
19. Hertog, M.G., & Hollman, P.C. (1996). Potential health effects of the dietary flavonol quercetin. Eur. J. Clin. Nutr., 50, 63-71.
20. Huk, I., Brovkovich, V., Nanobash, V., Weigel, G., Neumayer, C., & Partyka, L. (1998). Bioflavonoid quercetin scavenges superoxide and increases nitric oxide concentration in ischaemia-reperfusion injury: an experimental study. Br. J. Surg., 85, 1080-1085.
21. Hytiroglou, P., Tobias, H., Saxena, R., Abramidou, M., Papadimitriou, C.S., & Theise, N.D. (2004). The canals of hering might represent a target of methotrexate hepatic toxicity. Am. J. Clin. Pathol., 121, 324-329.
22. Igura, K., Ohta, T., Kuroda, Y., & Kaji, K. (2001). Resvetatrol and quercetin inhibit angiogenesis in-vitro. Cancer Lett., 171, 11-16.
23. Jahovic, N., Sener, G., Cevik, H. Ersoy, Y., Arbak, S., & Yeǧen, B.C. (2004). Amelioration of methotrexate-induced enteritis by melatonin in rats. Cell Biochem. Funct., 22, 169-178.
24. Kamen, B.A., Nylen, P.A., Camitta, B.M., & Bertino, J.R. (1981). Methotrexate accumulation and folate depletion in cell as a possible mechanism of chronic toxicity to the drug. Br. J. Haematol., 49, 355-360.
25. Kishi, Y., Schmelzer, J.D., Yao, J.K., & Low, P.A. (1999). α-lipoic acid: Effect on glucose uptake, sorbitol pathway, and energy metabolism in experimental diabetic neuropathy. Diabetes, 48, 2045-2051.
26. Krawisz, J.E., Sharon, P., & Stenson, W.F. (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity: assessment of inflammation in rat and hamster models. Gastroenterology, 87, 1344-1350.
27. Kremer, J.M., Galivan, J., Streckfuss, A., & Kamen, B. (1986). Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Arthritis. Rheum., 29, 832-835.
28. Kroncke, K.D., Fehsel, K., & Kolb-Bachofen, V. (1998). Inducible nitric oxide synthase in human diseases. Clin. Exp. Immunol., 113, 147-156.
29. Lodge, J.K., Traber, M.G., & Packer, L. (1998). Thiol chelation of Cu 21 by dihydrolipoic acid prevents human low density lipoprotein peroxidation. Free Radic. Biol. Med., 25, 287-297.
30. Lorens, S., & Nava, E. (2003). Cardiovascular diseases and the nitric oxide pathway. Curr. Vasc. Pharmacol., 1, 335-346.
31. Lowry, O.H., Rosebrough, N.J., Farr, A.L., & Randall, R.G. (1951). Protein measurement with folin reagent. J. Biol. Chem., 193, 265-275.
32. Mantovani, G., Macciò, A., Esu, S., Lai, P., Santona, M.C., Massa, E., Dessi, D., Melis, G.B., & Del Giacco, G.S. (1997). Medroxyprogesterone acetate reduces the in-vitro production of cytokines and serotonin involved in anorexia/cachexia and emesis by peripheral blood mononuclear cells of cancer patients. Eur. J. Cancer, 33, 602-607.
33. Marklund, S., & Marklund, G. (1974). Involvement of superoxide anion radical in the oxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem., 47, 469-474.
34. Miranda, M., Espey, M.G., & Wink, D.A. (2001). A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide, 5, 62-71.
35. Moreira, A., Fraga, C., Alonso, M., Collado, P.S., Zettler, C., Marroni, N., & Gonzalez-Gallego, J. (2004). Quercetin prevents oxidative stress and NF-kB activation in gastric mucosa of portal hypertensive rats. Biochem. Pharmacol., 68, 1939-1946.
36. Ou, P., Tritschler, H.J., & Wolff, S.P. (1995). Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem. Pharmacol., 50, 123-126.
37. Packer, L., Witt, E.H., & Tritschler, H.J. (1995). Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med., 9, 227-250.
38. Pawlikowska-Pawlega ,B., Guszecki ,W.I., Misiak, L.E., & Gawron, A. (2003). The study of the quercetin action on human erythrocyte membranes. Biochem. Pharmacol., 66, 605-12.
39. Peet, G.W. & Li, J. (1999). IKappaB kinases alpha and beta show a random sequential kinetic mechanism and are inhibited by staurosporin and quercetin. J. Biol. Chem., 274, 32655-32661.
40. Peres, W., Tunon, M.J., Mato, S., Collado, P.S., Marroni, N., & Gonzalez-Gallego, J. (2000). Hepatoprotective effects of the flavonoid quercetin in rats with biliary obstruction. J. Hepatol., 33, 742-750.
41. Phillips, D.C., Woollard, K.J., & Griffiths, H.R. (2003). The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species. Br. J. Pharmacol., 138, 501-511.
42. Rauen, U., Li, T., Ioannidis, I., & de Groot, H. (2007). Nitric oxide increases toxicity of hydrogen peroxide against rat liver endothelial cells and hepatocytes by inhibition of hydrogen peroxide degradation. AJP-Cell Physiol., 292, C1440-C1449.
43. Romics, L., Kodys, K., Dolganiuc, A., Graham, L., Velayudham, A., Mandrekar, P.S., & Zabo, G. (2004). Diverse regulation of NF-kB and peroxisome proliferators-activated receptors in murine non-alcoholic fatty liver. Hepatology, 40, 376-385.
44. Sen, C.K. (1997). Nutritional biochemistry of cellular glutathione. J. Nutr. Biochem., 8, 660-672.
45. Silva, M.M., Santos, M.R., Caroco, G., Rocha, R., Justino, G., & Mira, L. (2002). Structure-antioxidant relationships of flavonoids: a reexamination. Free Radic. Res., 36, 1219-1227.
46. Srivastava, S.K. (1971). Metabolism of red cell glutathione. Exp. Eye Res., 11, 294-305.
47. Staal, F.J., Roederer, M., Herzenberg, L.A., & Herzenberg, L.A. (1990). Intracellular thiols regulate activation of NF-kB and transcription of human immunodeficiency virus. Proc. Natl. Acad. Sci., 87, 9943-9947.
48. Sugiyama, S., Hayakawa, M., Kato, T. Hanaki, Y., Shimizu, K., & Ozawa, T. (1989). Adverse effects of anti-tumor drug, cisplatin, on rat kidney mitochondria: disturbances in glutathione peroxidase activity. Biochem. Biophys. Res. Commun., 159, 1121-1127.
49. Sullivan, G.W., Sarembock, I.J., & Linden, J. (2000). The role of inflammation in vascular diseases. J. Leukoc. Biol., 67, 591-602.
50. Tobias, H. & Auerbach, R. (1973). Hepatotoxicity of long term methotrexate therapy for psoriasis. Arch. Intern. Med., 132, 391-396.
51. Uchiyama, M., & Mihara, M. (1978). Determination of malondialdehyde precursor in tissue by thiobarbituric acid method. Anal. Biochem., 86, 271-278.
52. Vaziri, N.D. (2004). Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin. Nephrol., 24, 469-473.
53. Vogel, W.H., Snyder, R., & Schulman, M.P. (1963). The inhibition of dehydrogenases by folic acid and several of its analogs. Biochem. Biophys. Res. Commun., 10, 97-101.
54. Vonen, B., & Morland, J. (1984). Isolated rat hepatocytes in suspension: potential hepatotoxic effects of six different drugs. Arch. Toxicol., 56, 33-37.
55. Walker, T.M., Rhodes, P.C., & Westmoreland, C. (2000). The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol. In Vitro, 14, 475-485.
56. Weijl, N.I., Cleton, F.J., & Osanto, S. (1997). Free radicals and antioxidants in chemotherapy-induced toxicity. Cancer Treat. Rev., 23, 209-240.
57. Wink, D.A., & Mitchell, J.B. (1998). Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic. Biol. Med., 25, 434-456.
58. Yang, K., Lamprecht, S.A., Liu, Y., Shinozaki, H., Fan, K., & Leung, D. (2000). Chemoprevention studies of the flavonoids quercetin and rutin in normal and azoxymethane- treated mouse colon. Carcinogenesis, 21, 1655-1660.
59. Zandi, E., Rothwarf, D.M., Delhase, M., Hayakawa, M., & Karin, M. (1997). The IkB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IkB phosphorylation and NF-kB activation. Cell, 91, 243-252.
60. Zhang, J.G., Zhong, L.F., Zhang, M., & Xia, Y.X. (1992). Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in-vitro. Arch. Toxicol., 66, 354-358.
61. Zhang, W. & Freil, B. (2001). α- Lipoic acid inhibits TNF-α-induced NF-kB activation and adhesion molecule expression in human aortic endothelial cells. FASEB J., 15, 2423-2432.